Department of Cardiology, Cardiocentro Ticino Institute-EOC, Lugano, Switzerland; Fondazione Ticino Cuore, Lugano, Switzerland.
Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Cardiac Arrest and Resuscitation Science Research Team (RESTART), Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Resuscitation. 2024 Apr;197:110113. doi: 10.1016/j.resuscitation.2024.110113. Epub 2024 Jan 12.
The Utstein Based-ROSC (UB-ROSC) score has been developed to predict ROSC in OHCA victims. Aim of the study was to validate the UB-ROSC score using two Utstein-based OHCA registries: the SWiss REgistry of Cardiac Arrest (SWISSRECA) and the Lombardia Cardiac Arrest Registry (Lombardia CARe), northern Italy.
Consecutive patients with OHCA of any etiology occurring between January 1st, 2019 and December 31st 2021 were included in this retrospective validation study. UB-ROSC score was computed for each patient and categorized in one of three subgroups: low, medium or high likelihood of ROSC according to the UB-ROSC cut-offs (≤-19; -18 to 12; ≥13). To assess the performance of the UB-ROSC score in this new cohort, we assessed both discrimination and calibration. The score was plotted against the survival to hospital admission.
A total of 12.577 patients were included in the study. A sustained ROSC was obtained in 2.719 patients (22%). The UB-ROSC model resulted well calibrated and showed a good discrimination (AUC 0.71, 95% CI 0.70-0.72). In the low likelihood subgroup of UB-ROSC, only 10% of patients achieved ROSC, whereas the proportion raised to 36% for a score between -18 and 12 (OR 5.0, 95% CI 2.9-8.6, p < 0.001) and to 85% for a score ≥13 (OR 49.4, 95% CI 14.3-170.6, p < 0.001).
UB-ROSC score represents a reliable tool to predict ROSC probability in OHCA patients. Its application may help the medical decision-making process, providing a realistic stratification of the probability for ROSC.
基于乌斯坦因的复苏后综合征(UB-ROSC)评分旨在预测院外心搏骤停(OHCA)患者的 ROSC。本研究旨在使用两个基于乌斯坦因的 OHCA 登记处(瑞士心脏骤停登记处[SWISSRECA]和意大利北部伦巴第心脏骤停登记处[Lombardia CARe])验证 UB-ROSC 评分。
本回顾性验证研究纳入了 2019 年 1 月 1 日至 2021 年 12 月 31 日期间发生的任何病因 OHCA 的连续患者。为每位患者计算 UB-ROSC 评分,并根据 UB-ROSC 截止值(≤-19;-18 至 12;≥13)分为低、中或高 ROSC 可能性的三个亚组之一。为了评估 UB-ROSC 评分在该新队列中的表现,我们评估了区分度和校准度。该评分与住院存活率进行了对比。
本研究共纳入 12577 例患者。2719 例(22%)患者获得持续 ROSC。UB-ROSC 模型结果校准良好,区分度良好(AUC 0.71,95%CI 0.70-0.72)。在 UB-ROSC 的低可能性亚组中,仅有 10%的患者实现了 ROSC,而评分在-18 至 12 之间的比例上升至 36%(OR 5.0,95%CI 2.9-8.6,p<0.001),评分≥13 的比例上升至 85%(OR 49.4,95%CI 14.3-170.6,p<0.001)。
UB-ROSC 评分是预测 OHCA 患者 ROSC 概率的可靠工具。其应用有助于医疗决策过程,提供 ROSC 可能性的现实分层。